TrialInternational journal of hematology2019

Post-treatment improvement of NK cell numbers predicts better survival in myeloma patients treated with thalidomide-based regimens.

Jorge Vela-Ojeda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.